Hubungan Soluble Fms Like Tyrosine Kinase-1 dan Placental Growth Factor dengan Preeklampsia
78
DAFTAR PUSTAKA
Agida ET, Adeka BI, Jibril KA. .,2010. Pregnancy Outcome in Preeclamptic at
The University of Abuja Teaching Hospital, Gwagwalada, Abuja: A 3
Year Review. Nigerian Journal of Clinical Practice..; Vol. 13; 4: 394-398
Ahmad Shakil, and Ahmed Asif. 2004. Elevated Placental Soluble Vascular
Endothelial Growth Factor receptor-1 Inhibits Angiogenesis in
Preeclampsia. Circulation Research. Journal of The American Heart
Association. : 95: 884-891
Ananth Cande V, Keyes Katherine M, Wapner Ronald J., 2013. Preeclampsia
rates in the United States, 1980-2010: age Period Cohort Analysis.
BMJ.; 347: 1-9
Anderson UD, Olsson MG, Kristensen KH, Akerstrom B, Hansson SR. Review:
Biochemical Markers to Predict Preeclampsia. 2012. PLACENTA33,
Supplement A, Trophoblast Research.; vol. 26: s42-s47
Andraweera P H, Dekker G A, Roberts C T. 2012. The Vascular Endothelial
Growth Factor Family in Adverse Pregnancy Outcomes. Human
Reproduction Update.; vol. 18: 436-457
Badan Kependudukan dan Keluarga Berencana Nasional. 2012 dalam Survey
Kesehatan dan Demografi Indonesia. 2013. Jakarta; Indonesia; hal 213
Barton J R and Sibai B M. 2008. Prediction and Prevention of Recurrent
Preeclampsia. Obstet Gynecol. ; 112(2): 359-72
Chappell Lucy C, Duckworth Suzy, Seed Paul T, Griffin Melanie, Myers Jenny,
Mackillop Lucy, Simpson Ngel, Waugh Jason, Anumba Dilly et al. 2013.
Diagnostic Accuracy of Placental Growth Factor in Women with
Suspected Preeclampsia: A Prospective Multicenter Study. Circulation
Research. Journal of The American Heart Association.; 128: 2121-2131
Chen Yu. 2009. Novel Angiogenic Factor for Predicting Preeclampsia: sFlt-1,
PlGF and Soluble Endoglin. The Open Clinical Chemistry Journal.; 2:
1-6
Costa F S, Murthi P, Keogh R, Woodrow N. . 2011.Early Screening for
Preeclampsia. Rev Bras Ginecol Obstet; 33 (11): 367-75
Cunningham FG, et al. 2010. Pregnancy hypertension. In Williams Obstetrics,
23nd ed., pp. 706–755. New York: McGraw-Hill
Universitas Sumatera Utara
79
Eiland Elosha, Nzerue Chuke, Faulkner Marquetta. 2012. Review Article
Preeclampsia 2012. Journal of Pregnancy.: 1-7
Gilbert J S, Ryan m J, Lamarca B B, Sedeek M, Murphy S R and Granger J P.
2008. Pathophysiology of Hypertension During Preeclampsia: Linking
Placental Ischemia with Endothelial Dysfunction. Am. J Physiol Heart
Circ Physiol; (294): H541-H550
Grill S, Rusterholz C, Dallenbach RZ, Tercanli S, Holzgreve W, Hahn S, and
Lapaire O. 2009.
Potential Markers of Preeclampsia- A Review.
Reproductive Bilogy and Endocrinology.; 7 (70): 1-14
Gu Y, Lewis D F and Wang y. 2008. Placental Productions and Expressions of
Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1 and
Placental Growth Factor in Normal and Preeclamptic Pregnancies. J
Clin Endocrin ol Metab.; 93(1): 260-266
Hagmann Henning, Thadhani Ravi, Benzing Thomas, Karumanchi S Ananth,
Stephan Holger. 2012. The Promise of Angiogenic Markers for the
Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry.;
58: 5. 837-845
Hanita O, Alia N N, Zaleha A M, Azlin M N. 2014. Serum Soluble FMS-Like
Tyrosine Kinase 1 and Placental Growth Factor Concentration as
Predictors of Preeclampsia in High Risk Pregnant Women. Malaysian J.
Pathol.; 36: 19-26
Harris L K. 2011. Transformation of The Spiral Arteries in Human Pregnancy:
Key Event in The Remodelling Timeline. J. Placenta; Vol 25; (32): s154s158
Hassan Mahmoud Fathy,
Husseiny. 2013.
Tyrosine Kinase-1
Useful Predictor
International.; 1-8
Rund Nancy Mohamed Ali and Salama Ahmed
An Elevated maternal Plasma Soluble fms Like
to Plaental Growth Factor Ratio at Midtrimester is a
for Preeclampsia.
Obstetrics and Gynecology
Hernawati, Ina. 2011. Analisis Kematian Ibu di Indonesia. Dalam Paparan
Direktur pada Pertemuan teknis Kesehatan ibu. 6 April 2011.
Hirashima, C.; Ohkuchi, A.; Arai, F.; Takahashi, K.; Suzuki, H.;Watanabe,
T.;Kario, K.; Matsubara, S.; Suzuki, M. 2005. Establishingreference
values for both total soluble Fms-like tyrosine kinase 1and free placental
growth factor in pregnant women. Hypertens.Res. 28(9), 727-732.
Universitas Sumatera Utara
80
Hui Dini, Okun Nan, Murphy Kellie, Kingdom John, Uleryk Elizabeth, Shah
Prakesh S. . 2012. Combination of Maternal Serum Markers to Predict
Preeclampsia, Small for Gestational Age and Stillbirth: A Systematic
Review. Journal Obstetric Gynecology Canada; 34(2): 142-153
Hunter Alyson, Aitkenhead Mark, Caldwell Carolyn, McCracken Geoffrey,
Wilson David and McClure Neil. 2000. Serum Levels of Vascular
Endothelial Growth Factor in Preeclamptic and Normotensive
Pregnancy. Hypertension. American Heart Association Journals.; 36:
965-969
Jacobs Marni, Nassar Natasha, Roberts Christine L, Hadfield Ruth, Morris
Jonathan M and Ashton Anthony W. 2011. Levels of Soluble fms-lik
Tyrosine Kinase One in First Trimester and Outcomes of Pregnancy: a
Systematic Review. Reproductive Biology and Endrocinology. ; 9:1-8
Jido T A, Yakasai I A. 2013. Preeclampsia: a Review of The Evidence. Annals
of African Medicine.; vol 12: 75-86
Kapiteijn Catharina Johanna. 2006.
Pregnancy.
Angiogenesis and The Inception of
Karumanchi SA, Epstein F H. 2007. Placental Ischemia and Soluble fms-Like
Tyrosine Kinase 1: Cause or Consequence of Preeclampsia ? Kidney
International.; 71: 959-961
Kemenkes. 2008.
Angka Kematian Ibu Melahirkan.
Diunduh dari :
http://menegpp.go.id/v2/index.php/datadaninformasi/kesehatan?downloa
d=23%3Aangka-kematian-ibu-melahirkan-akiWHO
Kemenkes, 2011. Profil Data Kesehatan Indonesia tahun 2011. Diunduh dari
http://www.depkes.go.id
Kemenkes. 2012. Tren Angka Kematian Ibu sejak 1992 sampai tahun 2012 dalam
SDKI 2012.
Ki Shin Young, Lim J H, Yang J H, Kima M Y, Han J Y, Ahn H K, Choi J S,
Park S Y, Kim M J and Ryu H M. 2008. Dinucleotide Repeat
Polymorphism in Fms Like Tyrosine Kinase I (Flt-I) Gene Is Not
Associated with Preeclampsia. BMC Medical Genetics. ; 9(68): 1-6
Universitas Sumatera Utara
81
Kim Shin Young, Ryu Hyun Mee, Yang Jae Hyug, Kim Moon Young, Han Jung
Yeol, Kim Joo Oh, Chung Jin Hoon, Park So Yeon, Lee Moon Hee, Kim
Do Jin. 2007. Increased sFlt-1 to PlGF Ratio in Women Who
Subsequently Develop Preeclampsia. Journal Korean Med Science.; 22:
873-7
Knofler M, Pollheimer J. 2012. Molecular Regulation of Human Trophoblast
Invasion. Placenta 33, Supp A Trophoblast Reseaerch. . Vol 26: s55-s62
Lapaire O, Grill Simon, Lalevee S, Kolla V, Hosl I, Hahn S. 2012. Microarray
Screening for Novel Preeclampsia Biomarker Candidates.
Fetal
Diagnosis Therapy. ; 31: 147-153
Leif Matthiesen, Berg Goran, Ernerudh Jan, Ekerfelt Christina, Jonsson Yvonne,
Sharma Surendra.
2005. Immunology of Preeclampsia.
Chem
Immunology Allergy. Basel, Karger.; vol. 89: 49-61
Levine, R.J.; Maynard, S.E.; Qian, C.; Lim, K.H.; England, L.J.; Yu, K.F.;
Schisterman, E.F.; Thadhani, R.; Sachs, B.P.; Epstein, F.H.; Sibai, B.M.;
Sukhatme, V.P.; Karumanchi, S.A., 2004. Circulatingangiogenic factors
and the risk of preeclampsia. N. Engl. J. Med.,, 350(7), 672-683.
Levine R J, Lam C, Qian C, Yu K F, Maynard S E, Sachs B P, Sibai B M, Epstein
F H, Romero Roberto, Thadhani Ravi, Karumanchi S A. 2006. Soluble
Endoglin
and Other Circulating Antiangiogenic Factors in
Preeclampsia. The New England Journal of Medicine. ; 355: 992-1005
Lim Ji Hyae, Kim Shin Young, Park So Yeon, Yang Jae Hyug, Ki Moon Young,
Ryu Hyun Mee. 2008. Effective Prediction of Preeclampsia by a
Combined Ratio of Angiogenesis-Related Factors. Obstetric and
Gynecology.; vol. 111: 1403-1409
Lindheimer M D, Taler S J, Cunningham F G. 2010. Hypertension in Pregnancy.
Journal of The American Society of Hypertension. ; 4(2): 68-78
Liu Linda Y, Yang T, Ji, J, Wen Q, Morgan A A, Jin B, Chen G, Lyell D J,
Stevenson D K, Ling Xuefeng B, Butte A J. 2013. Integrting Multiple
‘Omic’ Analyses Identifies Serological Protein Biomarkers for
Preeclampsia. BMC Medicine.; 11 (236): 1-12
Makris A, Thomton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R,
McKenzie P, Kirwan P and Hennessy A. 2007. Uteroplacental Ischemia
Results in Proteinuric Hypertension and Elevated sFLT-1. Kidney
International.; 71: 977-984
Universitas Sumatera Utara
82
Matsubara keiichi, Matsubara Yuko, Ito M. 2009. The Utility of Vascular
Dysfunction Studies in The Prediction and Prevention of Preeclampsia: a
Historical Review. Vascular Disease Prevention.; 6: 163-169
Maynard S E, Min J Y, Merchan J, Lim Kee Hak, Li Jianyi, Mondal S, Libermann
T A, Morgan J P, Sellke F W, Stillman I E, Epstein F H, Sukhatme V P,
and Karumanchi S A. 2003. Excess Placental Soluble fms-Like Tyrosine
Kinase 1 (sFlt-1) may Contribute to Endothelial Dysfunction,
Hypertension and Proteinuria in Preeclampsia. J. Clin. Invest.; 111:
649-658
Maynard S E, Venkatesha S, Thadhani R, and Karumanchi S A. 2005. Soluble
Fms-Like Tyrosine Kinase 1 and Endothelial Dysfunction in the
Pathogenesis of Preeclampsia. Pediatric Research.; Vol. 57: 1-7
Mcelrath t F, Lim K H, Pare E, Edwards J R, Pucci D, Troisi R, Parry S. 2012.
Longitudinal Evaluation of Predictive Value for Preeclampsia of
Circulating Angiogenic Factors Through Pregnancy. Am j Obstet
Gynecol.; 207: 1-7
Mihalceanu Elena, Crauciuc Eduard, Toma Ovidiu, Ungureanu Eugen, Crauciuc
Dragos, Onofriescu Mircea. 2013. Angiogenic Protein Ratio sFlt-1 /
PlGF The Predictive Value for Preeclampsia. Analele Ştiinţifice ale
Universităţii „Alexandru Ioan Cuza”, Secţiunea Genetică şi Biologie
Moleculară, TOM XIV,
Mikat B, Gellhaus A, Wagner N, Birdir C, Kimmig R, and Koninger A. 2012.
Review Article Early Detection of Maternal Risk for Preeclampsia.
ISRN Obstetrics and Gynecology. ; 1-7
Moghadam A D, Khosravi A, Sayehmiri K. 2012. Predictive Factors for
Preeclampsia in Pregnant Women: an Unvariate and Multivariate
Logistic Regression Analysis. ACTABP.; Vol 59, No. 4: 673-677
Moore Simas, T.A.; Crawford, S.L.; Solitro, M.J.; Frost, S.C.;Meyer, B.A.;
Maynard, S.E.
2007. Angiogenic factors for the predictionof
preeclampsia in high-risk women. Am. J. Obstet. Gynecol.,197(3),
244.el-8.
Murphy S R, Lamarca B B D, Parrish M, Cockrell K, Granger J P. 2012. Control
of Sluble Fms Like Tyrosine -1 (sFlt-1) Production Response to Placental
Ischemia / Hypoxia: Role of Tumor Necrosis Factor –α. American
Journal Physiol Regul Integr Comp Physiol.; 304: R130-R135
Mutter W P, Karumanchi S A. 2008. Molecular Mechanisms of Preeclampsia.
Microvascular Research.; 75: 1-8
Universitas Sumatera Utara
83
Myatt L, Clifton R G, Roberts J M, Spong C Y, Hauth J C, Varner M W, Thorp j
M, Mercer B M, Peaceman a M, Ramin S M, Carpenter M W, Iams J D,
Sciscione A, Harper M, Tolosa J E, Saade G, Sorokin Y, Anderson D G.
2012.
First Trimester Prediction of Preeclampsia in Low Risk
Nulliparous Women. Journal of Obstet and Gynecology.; 119: 12341242
Myers J E, Kenny L C, McCowan L M E, Chan E H Y, Dekker G A, Poston ,
Simpson n A B, North R . 2013. Angiogenic Factors Combined with
Clinical Risk Factors to Predict Preterm Pre-Eclampsia in Nulliparous
Women : a Predictive Test Accuracy Study.International Journal of
Obstetric and Gynecology. ; 1-9
Nelson S M and Greer I A. 2006. Hypertensive Disorders of Pregnancy:
Preventative, Immediate and Long Term Management. Expert Rev.
Pharmacoeconomics Outcomes Res. ; 6: 541-554
Neufeld G, Cohen T, Gengrinovitch Stela, and Poltorak Z. 1999. Vascular
Endothelial Growth Factor and Its Receptors. The FASEB Journal.;
Vol. 13: 1-14
Noori Muna, Donald Ann E, Angelakopoulou Aspasia, Hingorani Aroon D,
Williams David J. 2010. Prospective Study of Placental Angiogenic
Factors and Maternal Vascular Function Before and After Preeclampsia
and Gestationl Hypertension. Circulation Research. Journal of The
American Heart Association. ; 122: 478-487
Noris M, Perico N, and Giuseppe R. 2005. Review:Mechanisms of Disease: PreEclampsia.Nature Clinical Practice Nephrology.; Vol 1(2): 98-114
Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, 2000. Austgulen R.Risk factors
and clinical manifestations of pre-eclampsia. BJOG; 107: 1410-6
Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y and Suzuki M.
2011. Threshold of Sluble Fms-Like Tyrosine Kinase 1/ Placental
Growth Factor Ratio for The Imminent Onset of Preeclampsia.
Hypertension Journal of The American Heart Association. ; 58: 859-866
Pennington kathleen A, Schlitt jessica M, Jackson Daniel L, Schulz Laura C,
Schust Danny J. 2012. Preeclampsia : Multiple Approaches for a
Multifactorial Disease. Disease Models and Mechanisms. ; 5: 9-18
Petla L T, Chikkala R, Ratnakar K S, Kodati V, Sritharan V. 2013. Biomarkers
for The management of Preeclampsia of Preeclampsia in Pregnant
Women. Indian J Med Res.; 138: 60-7
Universitas Sumatera Utara
84
Powe Camille E, Levine Richard J, Karumanchi S Ananth. 2011. Preeclampsia, a
Disease of the Maternal Endothelium: The Role of Antiangiogenic
Factors and Implications for Later Cardiovascular Disease. Circulation
Research. Journal of The American Heart Association.; 123: 2856-2869
Powers Rober W, Jeyabalan Arun, Clifton Rebecca G, Dorsten PV, Hauth J C,
Klebanoff MA, Lindheimer M D, Sibai Baha, Landon Mark, Miodovnik
Menachem. 2010. Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin
and Placental Growth Factor (PlGF) in Preeclampsia among High Risk
Pregnancies. PLoS ONE.; 5:1-12
Redman C W and Sargent I L. 2009. Placental Stress and Preeclampsia: a
Revised View. Placenta.; 30: 38-42
Ringkasan Kajian Kesehatan Ibu dan Anak. Unicef Indonesia. Oktober 2012
Roberts J M and Escudero C. 2012. The Placenta in Preeclampsia. Pregnancy
Hypertens. ; 2: 72-83
Roberts J M and Hubel. 2008. The Two Stage Model of Preeclampsia: Variations
on The Theme. Placenta. : 1-6
Robert J M and Rajakumar A. 2009. Preeclampsia and Soluble Fms Like
Tyrosine Kinase 1. J Clin Endocrinol Metab. ; 94: 2252-2254
Rogers M S, 2007. Prediction of Preeclampsia in Early Pregnancy.. Women’s
Health.; 3: 571-583
Rolfo A, Giuffrida D, Nuzzo A M, Pierobon D, Cardaropoli S, Piccoli E,
Giovarelli M, Todros T. 2013. Pro Inflammatory Profile of Preeclamptic
Placental Mesenchymal Stromal Cells: New Insights into The
Etiopathogenesis of Preeclampsia. PLoS One.; Vol. 8: 1-13
Romero R, Nien JK, Espinoza J, Todem David, Fu Wenjiang, Chung Hwan,
Kusanovic Juan Pedro, Gotsch Francesca, Erez Offer, Mazaki-tovi Shali,
Gomez Ricardo, Edwin Sam, Chaiworapongsa T, Levine R J,
Karumanchi A. 2008. A longitudinal study ofangiogenic (placental
growth factor) and anti-angiogenic (solubleendoglin and soluble
vascular endothelial growth factor receptor-1)factors in normal
pregnancy and patients destined to developpreeclampsia and deliver a
small for gestational age neonate. JMatern Fetal Neonatal Med. 21: 9–23
Romero Roberto and Chaiworapongsa T. 2013. Preeclampsia: a Link Between
Trophoblast Dysregulation and an Antiangiogenic State. The Journal of
Clinical Investigation. ; 123: 1- 4
Universitas Sumatera Utara
85
Rozhikan. 2007. Faktor-Faktor Risiko Terjadinya Preeklampsia Berat Di Rumah
Sakit dr. H. Soewondo Kendal. Tesis. Universitas Diponegoro.
Semarang;
Sado T, Naruse K, Noguchi T, Haruta S, Yoshida S, Tanase Y, Kitanaka T, Oi H,
Kobayashi H. 2011. Inflammatory Pattern Recognition Receptors and
Their Ligands: Factors Contributing to Th Pathogenesis of
Preeclampsia. ; 1-13
Savaj Shokoufeh and Vaziri N D. 2012. An Overview of Recent Advances in
Pathogenesis and Diagnosis of Preeclampsia. IJKD.: 334-8
Savvidou MD, Akolekar R, Zaragoza E, Poon L C, Nicolaides K H. 2009. First
Trimester Urinary Placental Growth factor and Development of
Preeclampsia. BJOG.; 116: 643-647
Schmidt
Markus, Dogan Canan, Birdir Canan, Kuhn Ulrich, Gllhaus
Alexandra, Kimmig Rainer, Bauer Sabine Kasimir. 2009. Placental
Growth Factor: A Predictive Marker for Preeclampsia? .
Gynakol
Geburtshilfliche Rundsch.; 49: 94-99
Selim M E, Elshmry N G, and Rashed E H. 2013. The Role of Novel Biomarker
in Early Predicton of Preeclampsia in Pregnant Rats. J. Blood Disorders
and Transfusion.; 4: 1-5
Shibuya M. 2006. Differential Roles of Vascular Endothelial Growth Factor
Receptor-1 and Receptor-2 in Angiogenesis. Journal of Biochemistry
and Molecular Biology. ; Vol 39 (5): 469-478.
Shibuya M. 2011. Review Involvement of Flt-1 (VEGF receptor-1) in Cancer and
Preeclampsia. Proceedings of The Japan Academy, Series B Physical
and Biological Scieces.; 87 (4): P. 167-179
Shibuya M. 2013. Vascular Endothelial Growth Factor and Its Receptor System:
Physiological Functions in Angiogenesis and Pathological Roles in
Various Diseases. Journal of Biochemistry.; 153: 13-19
Sibai B, Dekker G, Kupferminc M. 2005. Preeclampsia. The Lancet.. Vol. 365,
Issue 9461: 785-799
Sibiude jeanne, guibourdenche Jean, Dionne M D, Ray C L, Anselem O, Serreau
R, Goffinet F, Tsatsaris V. 2012. Placental Growth Factor for the
Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia
or Intrauterine Growth Restriction. PLoS One.; 7: 1-8
Universitas Sumatera Utara
86
Soto E, Romero R, Kusanovic J P, Ogge G, Hussein Y, Yeo L, Hassan S S, Kim
C J, Chaiworapongsa T. 2012. Late Onset Preeclampsia is Associated
with an Imbalance of Angiogenic and Anti Angiogenic Factors in
Patients With and Without Placental Lesions Consistent With Maternal
Underperfusion. J Matern Fetal Neonatal Med.; 25: 498-507
Tjoa ML, van Vugt JM, Mulders MA,Schutgens RB, Oudeians CB, Van Wijk IJ.
2001. Plasma placentagrowth factor levels in midtrimester pregnancies.
Obstet Gynecol; 98: 600-7.
Torry, D.S.; Mukherjea, D.; Arroyo, J.; Torry, R.J. Expression andfunction of
placenta growth factor: implications for abnormal placentation. 2003. J.
Soc. Gynecol. Investig.; 10(4), 178-188.
Unicef, 2012. Ringkasan Kajian Kesehatan Ibu dan Anak. Jakarta: 1-6
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J M. 2011. Preeclampsia:
Pathophysiology, Diagnosis and Management. Vascular Health and Risk
Management;: 467-474
Verdonk Koen, Visser Willy, Russcher Henk, Danser A H Jan, Steegers Eric A P
and Meiracker Anton H van den. 2012. Differential Diagnosis of
Preeclampsia: Remember the Soluble FMs-Like Tyrosine Kinase
1/Placental Growth Factor Ratio. Hypertension. American Heart
Association Journals.; 60: 884-890
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler Harald,
Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. 2011.
The sFlt-1/PlGF Ratio in Different Types of Hypertensive Pregnancy
Disorders and Its Prognostic Potential in Preeclamptic Patients.
American Journal of Obstetric and Gynecology. ; 206: 1-8
Wagner L K. 2004. Diagnosis and Management of Preeclampsia. American
Family Physician. ; Vol 70, Number 12: 2317-2324
Wang Alice, Rana Sarosh, Karumanchi S Ananth. 2009. Preeclampsia: The
Role of Angiogenic Factors in Its Pathogenesis. Physiology. : 24: 147158
Wu F T H, Stefanini M O, Gabhann F M, Kontos C D, Annex B H, Popoel A S.
A . 2010. Systems Biology Perspective on sVEGFR1: Its Biological
Function, Patogenic Role and Therapeutic Use. J Cell Mol Med.; 14:
528-552
Universitas Sumatera Utara
87
Yamamoto Tatsuo, Chishima Fumihisa, Matsuura Masahiko. 2013. Prediction of
Preeclampsia
Using
Angiogenic
and
Antiangiogenic
Factors.Hypertension Research in Pregnancy. ; 1: 66-70
Zhong Yan. Tuuli M, and Odibo A O. 2010. First Trimester Assessment of
Placenta Function and The Prediction of Preeclampsia and Intrauterine
Growth Restriction. Prenatal Diagnosis.; 30: 293-308
Zhou Qiong, Qiao Fu-Yuan, Zhao Chang, Liu Hai-Yi. 2011. Hypoxic
Trophoblast-derived sFlt-1 May Contribute to Endothelial Dysfunction:
Implication for the Mechanism of Trophoblast-Endothelial Dysfunction
in Preeclampsia. Cell Biology International.; 35: 61-66
Zibaeenezhad MJ, Ghodsi M, Arab P, Gholzom. 2010.
Prevalence of
Hypertensive Disorders of Pregnancy in Shiraz, Southern Iran. Iranian
Cardiovascular Research Journal. ; vol 4: 169-172
Universitas Sumatera Utara
DAFTAR PUSTAKA
Agida ET, Adeka BI, Jibril KA. .,2010. Pregnancy Outcome in Preeclamptic at
The University of Abuja Teaching Hospital, Gwagwalada, Abuja: A 3
Year Review. Nigerian Journal of Clinical Practice..; Vol. 13; 4: 394-398
Ahmad Shakil, and Ahmed Asif. 2004. Elevated Placental Soluble Vascular
Endothelial Growth Factor receptor-1 Inhibits Angiogenesis in
Preeclampsia. Circulation Research. Journal of The American Heart
Association. : 95: 884-891
Ananth Cande V, Keyes Katherine M, Wapner Ronald J., 2013. Preeclampsia
rates in the United States, 1980-2010: age Period Cohort Analysis.
BMJ.; 347: 1-9
Anderson UD, Olsson MG, Kristensen KH, Akerstrom B, Hansson SR. Review:
Biochemical Markers to Predict Preeclampsia. 2012. PLACENTA33,
Supplement A, Trophoblast Research.; vol. 26: s42-s47
Andraweera P H, Dekker G A, Roberts C T. 2012. The Vascular Endothelial
Growth Factor Family in Adverse Pregnancy Outcomes. Human
Reproduction Update.; vol. 18: 436-457
Badan Kependudukan dan Keluarga Berencana Nasional. 2012 dalam Survey
Kesehatan dan Demografi Indonesia. 2013. Jakarta; Indonesia; hal 213
Barton J R and Sibai B M. 2008. Prediction and Prevention of Recurrent
Preeclampsia. Obstet Gynecol. ; 112(2): 359-72
Chappell Lucy C, Duckworth Suzy, Seed Paul T, Griffin Melanie, Myers Jenny,
Mackillop Lucy, Simpson Ngel, Waugh Jason, Anumba Dilly et al. 2013.
Diagnostic Accuracy of Placental Growth Factor in Women with
Suspected Preeclampsia: A Prospective Multicenter Study. Circulation
Research. Journal of The American Heart Association.; 128: 2121-2131
Chen Yu. 2009. Novel Angiogenic Factor for Predicting Preeclampsia: sFlt-1,
PlGF and Soluble Endoglin. The Open Clinical Chemistry Journal.; 2:
1-6
Costa F S, Murthi P, Keogh R, Woodrow N. . 2011.Early Screening for
Preeclampsia. Rev Bras Ginecol Obstet; 33 (11): 367-75
Cunningham FG, et al. 2010. Pregnancy hypertension. In Williams Obstetrics,
23nd ed., pp. 706–755. New York: McGraw-Hill
Universitas Sumatera Utara
79
Eiland Elosha, Nzerue Chuke, Faulkner Marquetta. 2012. Review Article
Preeclampsia 2012. Journal of Pregnancy.: 1-7
Gilbert J S, Ryan m J, Lamarca B B, Sedeek M, Murphy S R and Granger J P.
2008. Pathophysiology of Hypertension During Preeclampsia: Linking
Placental Ischemia with Endothelial Dysfunction. Am. J Physiol Heart
Circ Physiol; (294): H541-H550
Grill S, Rusterholz C, Dallenbach RZ, Tercanli S, Holzgreve W, Hahn S, and
Lapaire O. 2009.
Potential Markers of Preeclampsia- A Review.
Reproductive Bilogy and Endocrinology.; 7 (70): 1-14
Gu Y, Lewis D F and Wang y. 2008. Placental Productions and Expressions of
Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1 and
Placental Growth Factor in Normal and Preeclamptic Pregnancies. J
Clin Endocrin ol Metab.; 93(1): 260-266
Hagmann Henning, Thadhani Ravi, Benzing Thomas, Karumanchi S Ananth,
Stephan Holger. 2012. The Promise of Angiogenic Markers for the
Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry.;
58: 5. 837-845
Hanita O, Alia N N, Zaleha A M, Azlin M N. 2014. Serum Soluble FMS-Like
Tyrosine Kinase 1 and Placental Growth Factor Concentration as
Predictors of Preeclampsia in High Risk Pregnant Women. Malaysian J.
Pathol.; 36: 19-26
Harris L K. 2011. Transformation of The Spiral Arteries in Human Pregnancy:
Key Event in The Remodelling Timeline. J. Placenta; Vol 25; (32): s154s158
Hassan Mahmoud Fathy,
Husseiny. 2013.
Tyrosine Kinase-1
Useful Predictor
International.; 1-8
Rund Nancy Mohamed Ali and Salama Ahmed
An Elevated maternal Plasma Soluble fms Like
to Plaental Growth Factor Ratio at Midtrimester is a
for Preeclampsia.
Obstetrics and Gynecology
Hernawati, Ina. 2011. Analisis Kematian Ibu di Indonesia. Dalam Paparan
Direktur pada Pertemuan teknis Kesehatan ibu. 6 April 2011.
Hirashima, C.; Ohkuchi, A.; Arai, F.; Takahashi, K.; Suzuki, H.;Watanabe,
T.;Kario, K.; Matsubara, S.; Suzuki, M. 2005. Establishingreference
values for both total soluble Fms-like tyrosine kinase 1and free placental
growth factor in pregnant women. Hypertens.Res. 28(9), 727-732.
Universitas Sumatera Utara
80
Hui Dini, Okun Nan, Murphy Kellie, Kingdom John, Uleryk Elizabeth, Shah
Prakesh S. . 2012. Combination of Maternal Serum Markers to Predict
Preeclampsia, Small for Gestational Age and Stillbirth: A Systematic
Review. Journal Obstetric Gynecology Canada; 34(2): 142-153
Hunter Alyson, Aitkenhead Mark, Caldwell Carolyn, McCracken Geoffrey,
Wilson David and McClure Neil. 2000. Serum Levels of Vascular
Endothelial Growth Factor in Preeclamptic and Normotensive
Pregnancy. Hypertension. American Heart Association Journals.; 36:
965-969
Jacobs Marni, Nassar Natasha, Roberts Christine L, Hadfield Ruth, Morris
Jonathan M and Ashton Anthony W. 2011. Levels of Soluble fms-lik
Tyrosine Kinase One in First Trimester and Outcomes of Pregnancy: a
Systematic Review. Reproductive Biology and Endrocinology. ; 9:1-8
Jido T A, Yakasai I A. 2013. Preeclampsia: a Review of The Evidence. Annals
of African Medicine.; vol 12: 75-86
Kapiteijn Catharina Johanna. 2006.
Pregnancy.
Angiogenesis and The Inception of
Karumanchi SA, Epstein F H. 2007. Placental Ischemia and Soluble fms-Like
Tyrosine Kinase 1: Cause or Consequence of Preeclampsia ? Kidney
International.; 71: 959-961
Kemenkes. 2008.
Angka Kematian Ibu Melahirkan.
Diunduh dari :
http://menegpp.go.id/v2/index.php/datadaninformasi/kesehatan?downloa
d=23%3Aangka-kematian-ibu-melahirkan-akiWHO
Kemenkes, 2011. Profil Data Kesehatan Indonesia tahun 2011. Diunduh dari
http://www.depkes.go.id
Kemenkes. 2012. Tren Angka Kematian Ibu sejak 1992 sampai tahun 2012 dalam
SDKI 2012.
Ki Shin Young, Lim J H, Yang J H, Kima M Y, Han J Y, Ahn H K, Choi J S,
Park S Y, Kim M J and Ryu H M. 2008. Dinucleotide Repeat
Polymorphism in Fms Like Tyrosine Kinase I (Flt-I) Gene Is Not
Associated with Preeclampsia. BMC Medical Genetics. ; 9(68): 1-6
Universitas Sumatera Utara
81
Kim Shin Young, Ryu Hyun Mee, Yang Jae Hyug, Kim Moon Young, Han Jung
Yeol, Kim Joo Oh, Chung Jin Hoon, Park So Yeon, Lee Moon Hee, Kim
Do Jin. 2007. Increased sFlt-1 to PlGF Ratio in Women Who
Subsequently Develop Preeclampsia. Journal Korean Med Science.; 22:
873-7
Knofler M, Pollheimer J. 2012. Molecular Regulation of Human Trophoblast
Invasion. Placenta 33, Supp A Trophoblast Reseaerch. . Vol 26: s55-s62
Lapaire O, Grill Simon, Lalevee S, Kolla V, Hosl I, Hahn S. 2012. Microarray
Screening for Novel Preeclampsia Biomarker Candidates.
Fetal
Diagnosis Therapy. ; 31: 147-153
Leif Matthiesen, Berg Goran, Ernerudh Jan, Ekerfelt Christina, Jonsson Yvonne,
Sharma Surendra.
2005. Immunology of Preeclampsia.
Chem
Immunology Allergy. Basel, Karger.; vol. 89: 49-61
Levine, R.J.; Maynard, S.E.; Qian, C.; Lim, K.H.; England, L.J.; Yu, K.F.;
Schisterman, E.F.; Thadhani, R.; Sachs, B.P.; Epstein, F.H.; Sibai, B.M.;
Sukhatme, V.P.; Karumanchi, S.A., 2004. Circulatingangiogenic factors
and the risk of preeclampsia. N. Engl. J. Med.,, 350(7), 672-683.
Levine R J, Lam C, Qian C, Yu K F, Maynard S E, Sachs B P, Sibai B M, Epstein
F H, Romero Roberto, Thadhani Ravi, Karumanchi S A. 2006. Soluble
Endoglin
and Other Circulating Antiangiogenic Factors in
Preeclampsia. The New England Journal of Medicine. ; 355: 992-1005
Lim Ji Hyae, Kim Shin Young, Park So Yeon, Yang Jae Hyug, Ki Moon Young,
Ryu Hyun Mee. 2008. Effective Prediction of Preeclampsia by a
Combined Ratio of Angiogenesis-Related Factors. Obstetric and
Gynecology.; vol. 111: 1403-1409
Lindheimer M D, Taler S J, Cunningham F G. 2010. Hypertension in Pregnancy.
Journal of The American Society of Hypertension. ; 4(2): 68-78
Liu Linda Y, Yang T, Ji, J, Wen Q, Morgan A A, Jin B, Chen G, Lyell D J,
Stevenson D K, Ling Xuefeng B, Butte A J. 2013. Integrting Multiple
‘Omic’ Analyses Identifies Serological Protein Biomarkers for
Preeclampsia. BMC Medicine.; 11 (236): 1-12
Makris A, Thomton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R,
McKenzie P, Kirwan P and Hennessy A. 2007. Uteroplacental Ischemia
Results in Proteinuric Hypertension and Elevated sFLT-1. Kidney
International.; 71: 977-984
Universitas Sumatera Utara
82
Matsubara keiichi, Matsubara Yuko, Ito M. 2009. The Utility of Vascular
Dysfunction Studies in The Prediction and Prevention of Preeclampsia: a
Historical Review. Vascular Disease Prevention.; 6: 163-169
Maynard S E, Min J Y, Merchan J, Lim Kee Hak, Li Jianyi, Mondal S, Libermann
T A, Morgan J P, Sellke F W, Stillman I E, Epstein F H, Sukhatme V P,
and Karumanchi S A. 2003. Excess Placental Soluble fms-Like Tyrosine
Kinase 1 (sFlt-1) may Contribute to Endothelial Dysfunction,
Hypertension and Proteinuria in Preeclampsia. J. Clin. Invest.; 111:
649-658
Maynard S E, Venkatesha S, Thadhani R, and Karumanchi S A. 2005. Soluble
Fms-Like Tyrosine Kinase 1 and Endothelial Dysfunction in the
Pathogenesis of Preeclampsia. Pediatric Research.; Vol. 57: 1-7
Mcelrath t F, Lim K H, Pare E, Edwards J R, Pucci D, Troisi R, Parry S. 2012.
Longitudinal Evaluation of Predictive Value for Preeclampsia of
Circulating Angiogenic Factors Through Pregnancy. Am j Obstet
Gynecol.; 207: 1-7
Mihalceanu Elena, Crauciuc Eduard, Toma Ovidiu, Ungureanu Eugen, Crauciuc
Dragos, Onofriescu Mircea. 2013. Angiogenic Protein Ratio sFlt-1 /
PlGF The Predictive Value for Preeclampsia. Analele Ştiinţifice ale
Universităţii „Alexandru Ioan Cuza”, Secţiunea Genetică şi Biologie
Moleculară, TOM XIV,
Mikat B, Gellhaus A, Wagner N, Birdir C, Kimmig R, and Koninger A. 2012.
Review Article Early Detection of Maternal Risk for Preeclampsia.
ISRN Obstetrics and Gynecology. ; 1-7
Moghadam A D, Khosravi A, Sayehmiri K. 2012. Predictive Factors for
Preeclampsia in Pregnant Women: an Unvariate and Multivariate
Logistic Regression Analysis. ACTABP.; Vol 59, No. 4: 673-677
Moore Simas, T.A.; Crawford, S.L.; Solitro, M.J.; Frost, S.C.;Meyer, B.A.;
Maynard, S.E.
2007. Angiogenic factors for the predictionof
preeclampsia in high-risk women. Am. J. Obstet. Gynecol.,197(3),
244.el-8.
Murphy S R, Lamarca B B D, Parrish M, Cockrell K, Granger J P. 2012. Control
of Sluble Fms Like Tyrosine -1 (sFlt-1) Production Response to Placental
Ischemia / Hypoxia: Role of Tumor Necrosis Factor –α. American
Journal Physiol Regul Integr Comp Physiol.; 304: R130-R135
Mutter W P, Karumanchi S A. 2008. Molecular Mechanisms of Preeclampsia.
Microvascular Research.; 75: 1-8
Universitas Sumatera Utara
83
Myatt L, Clifton R G, Roberts J M, Spong C Y, Hauth J C, Varner M W, Thorp j
M, Mercer B M, Peaceman a M, Ramin S M, Carpenter M W, Iams J D,
Sciscione A, Harper M, Tolosa J E, Saade G, Sorokin Y, Anderson D G.
2012.
First Trimester Prediction of Preeclampsia in Low Risk
Nulliparous Women. Journal of Obstet and Gynecology.; 119: 12341242
Myers J E, Kenny L C, McCowan L M E, Chan E H Y, Dekker G A, Poston ,
Simpson n A B, North R . 2013. Angiogenic Factors Combined with
Clinical Risk Factors to Predict Preterm Pre-Eclampsia in Nulliparous
Women : a Predictive Test Accuracy Study.International Journal of
Obstetric and Gynecology. ; 1-9
Nelson S M and Greer I A. 2006. Hypertensive Disorders of Pregnancy:
Preventative, Immediate and Long Term Management. Expert Rev.
Pharmacoeconomics Outcomes Res. ; 6: 541-554
Neufeld G, Cohen T, Gengrinovitch Stela, and Poltorak Z. 1999. Vascular
Endothelial Growth Factor and Its Receptors. The FASEB Journal.;
Vol. 13: 1-14
Noori Muna, Donald Ann E, Angelakopoulou Aspasia, Hingorani Aroon D,
Williams David J. 2010. Prospective Study of Placental Angiogenic
Factors and Maternal Vascular Function Before and After Preeclampsia
and Gestationl Hypertension. Circulation Research. Journal of The
American Heart Association. ; 122: 478-487
Noris M, Perico N, and Giuseppe R. 2005. Review:Mechanisms of Disease: PreEclampsia.Nature Clinical Practice Nephrology.; Vol 1(2): 98-114
Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, 2000. Austgulen R.Risk factors
and clinical manifestations of pre-eclampsia. BJOG; 107: 1410-6
Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y and Suzuki M.
2011. Threshold of Sluble Fms-Like Tyrosine Kinase 1/ Placental
Growth Factor Ratio for The Imminent Onset of Preeclampsia.
Hypertension Journal of The American Heart Association. ; 58: 859-866
Pennington kathleen A, Schlitt jessica M, Jackson Daniel L, Schulz Laura C,
Schust Danny J. 2012. Preeclampsia : Multiple Approaches for a
Multifactorial Disease. Disease Models and Mechanisms. ; 5: 9-18
Petla L T, Chikkala R, Ratnakar K S, Kodati V, Sritharan V. 2013. Biomarkers
for The management of Preeclampsia of Preeclampsia in Pregnant
Women. Indian J Med Res.; 138: 60-7
Universitas Sumatera Utara
84
Powe Camille E, Levine Richard J, Karumanchi S Ananth. 2011. Preeclampsia, a
Disease of the Maternal Endothelium: The Role of Antiangiogenic
Factors and Implications for Later Cardiovascular Disease. Circulation
Research. Journal of The American Heart Association.; 123: 2856-2869
Powers Rober W, Jeyabalan Arun, Clifton Rebecca G, Dorsten PV, Hauth J C,
Klebanoff MA, Lindheimer M D, Sibai Baha, Landon Mark, Miodovnik
Menachem. 2010. Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin
and Placental Growth Factor (PlGF) in Preeclampsia among High Risk
Pregnancies. PLoS ONE.; 5:1-12
Redman C W and Sargent I L. 2009. Placental Stress and Preeclampsia: a
Revised View. Placenta.; 30: 38-42
Ringkasan Kajian Kesehatan Ibu dan Anak. Unicef Indonesia. Oktober 2012
Roberts J M and Escudero C. 2012. The Placenta in Preeclampsia. Pregnancy
Hypertens. ; 2: 72-83
Roberts J M and Hubel. 2008. The Two Stage Model of Preeclampsia: Variations
on The Theme. Placenta. : 1-6
Robert J M and Rajakumar A. 2009. Preeclampsia and Soluble Fms Like
Tyrosine Kinase 1. J Clin Endocrinol Metab. ; 94: 2252-2254
Rogers M S, 2007. Prediction of Preeclampsia in Early Pregnancy.. Women’s
Health.; 3: 571-583
Rolfo A, Giuffrida D, Nuzzo A M, Pierobon D, Cardaropoli S, Piccoli E,
Giovarelli M, Todros T. 2013. Pro Inflammatory Profile of Preeclamptic
Placental Mesenchymal Stromal Cells: New Insights into The
Etiopathogenesis of Preeclampsia. PLoS One.; Vol. 8: 1-13
Romero R, Nien JK, Espinoza J, Todem David, Fu Wenjiang, Chung Hwan,
Kusanovic Juan Pedro, Gotsch Francesca, Erez Offer, Mazaki-tovi Shali,
Gomez Ricardo, Edwin Sam, Chaiworapongsa T, Levine R J,
Karumanchi A. 2008. A longitudinal study ofangiogenic (placental
growth factor) and anti-angiogenic (solubleendoglin and soluble
vascular endothelial growth factor receptor-1)factors in normal
pregnancy and patients destined to developpreeclampsia and deliver a
small for gestational age neonate. JMatern Fetal Neonatal Med. 21: 9–23
Romero Roberto and Chaiworapongsa T. 2013. Preeclampsia: a Link Between
Trophoblast Dysregulation and an Antiangiogenic State. The Journal of
Clinical Investigation. ; 123: 1- 4
Universitas Sumatera Utara
85
Rozhikan. 2007. Faktor-Faktor Risiko Terjadinya Preeklampsia Berat Di Rumah
Sakit dr. H. Soewondo Kendal. Tesis. Universitas Diponegoro.
Semarang;
Sado T, Naruse K, Noguchi T, Haruta S, Yoshida S, Tanase Y, Kitanaka T, Oi H,
Kobayashi H. 2011. Inflammatory Pattern Recognition Receptors and
Their Ligands: Factors Contributing to Th Pathogenesis of
Preeclampsia. ; 1-13
Savaj Shokoufeh and Vaziri N D. 2012. An Overview of Recent Advances in
Pathogenesis and Diagnosis of Preeclampsia. IJKD.: 334-8
Savvidou MD, Akolekar R, Zaragoza E, Poon L C, Nicolaides K H. 2009. First
Trimester Urinary Placental Growth factor and Development of
Preeclampsia. BJOG.; 116: 643-647
Schmidt
Markus, Dogan Canan, Birdir Canan, Kuhn Ulrich, Gllhaus
Alexandra, Kimmig Rainer, Bauer Sabine Kasimir. 2009. Placental
Growth Factor: A Predictive Marker for Preeclampsia? .
Gynakol
Geburtshilfliche Rundsch.; 49: 94-99
Selim M E, Elshmry N G, and Rashed E H. 2013. The Role of Novel Biomarker
in Early Predicton of Preeclampsia in Pregnant Rats. J. Blood Disorders
and Transfusion.; 4: 1-5
Shibuya M. 2006. Differential Roles of Vascular Endothelial Growth Factor
Receptor-1 and Receptor-2 in Angiogenesis. Journal of Biochemistry
and Molecular Biology. ; Vol 39 (5): 469-478.
Shibuya M. 2011. Review Involvement of Flt-1 (VEGF receptor-1) in Cancer and
Preeclampsia. Proceedings of The Japan Academy, Series B Physical
and Biological Scieces.; 87 (4): P. 167-179
Shibuya M. 2013. Vascular Endothelial Growth Factor and Its Receptor System:
Physiological Functions in Angiogenesis and Pathological Roles in
Various Diseases. Journal of Biochemistry.; 153: 13-19
Sibai B, Dekker G, Kupferminc M. 2005. Preeclampsia. The Lancet.. Vol. 365,
Issue 9461: 785-799
Sibiude jeanne, guibourdenche Jean, Dionne M D, Ray C L, Anselem O, Serreau
R, Goffinet F, Tsatsaris V. 2012. Placental Growth Factor for the
Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia
or Intrauterine Growth Restriction. PLoS One.; 7: 1-8
Universitas Sumatera Utara
86
Soto E, Romero R, Kusanovic J P, Ogge G, Hussein Y, Yeo L, Hassan S S, Kim
C J, Chaiworapongsa T. 2012. Late Onset Preeclampsia is Associated
with an Imbalance of Angiogenic and Anti Angiogenic Factors in
Patients With and Without Placental Lesions Consistent With Maternal
Underperfusion. J Matern Fetal Neonatal Med.; 25: 498-507
Tjoa ML, van Vugt JM, Mulders MA,Schutgens RB, Oudeians CB, Van Wijk IJ.
2001. Plasma placentagrowth factor levels in midtrimester pregnancies.
Obstet Gynecol; 98: 600-7.
Torry, D.S.; Mukherjea, D.; Arroyo, J.; Torry, R.J. Expression andfunction of
placenta growth factor: implications for abnormal placentation. 2003. J.
Soc. Gynecol. Investig.; 10(4), 178-188.
Unicef, 2012. Ringkasan Kajian Kesehatan Ibu dan Anak. Jakarta: 1-6
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J M. 2011. Preeclampsia:
Pathophysiology, Diagnosis and Management. Vascular Health and Risk
Management;: 467-474
Verdonk Koen, Visser Willy, Russcher Henk, Danser A H Jan, Steegers Eric A P
and Meiracker Anton H van den. 2012. Differential Diagnosis of
Preeclampsia: Remember the Soluble FMs-Like Tyrosine Kinase
1/Placental Growth Factor Ratio. Hypertension. American Heart
Association Journals.; 60: 884-890
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler Harald,
Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. 2011.
The sFlt-1/PlGF Ratio in Different Types of Hypertensive Pregnancy
Disorders and Its Prognostic Potential in Preeclamptic Patients.
American Journal of Obstetric and Gynecology. ; 206: 1-8
Wagner L K. 2004. Diagnosis and Management of Preeclampsia. American
Family Physician. ; Vol 70, Number 12: 2317-2324
Wang Alice, Rana Sarosh, Karumanchi S Ananth. 2009. Preeclampsia: The
Role of Angiogenic Factors in Its Pathogenesis. Physiology. : 24: 147158
Wu F T H, Stefanini M O, Gabhann F M, Kontos C D, Annex B H, Popoel A S.
A . 2010. Systems Biology Perspective on sVEGFR1: Its Biological
Function, Patogenic Role and Therapeutic Use. J Cell Mol Med.; 14:
528-552
Universitas Sumatera Utara
87
Yamamoto Tatsuo, Chishima Fumihisa, Matsuura Masahiko. 2013. Prediction of
Preeclampsia
Using
Angiogenic
and
Antiangiogenic
Factors.Hypertension Research in Pregnancy. ; 1: 66-70
Zhong Yan. Tuuli M, and Odibo A O. 2010. First Trimester Assessment of
Placenta Function and The Prediction of Preeclampsia and Intrauterine
Growth Restriction. Prenatal Diagnosis.; 30: 293-308
Zhou Qiong, Qiao Fu-Yuan, Zhao Chang, Liu Hai-Yi. 2011. Hypoxic
Trophoblast-derived sFlt-1 May Contribute to Endothelial Dysfunction:
Implication for the Mechanism of Trophoblast-Endothelial Dysfunction
in Preeclampsia. Cell Biology International.; 35: 61-66
Zibaeenezhad MJ, Ghodsi M, Arab P, Gholzom. 2010.
Prevalence of
Hypertensive Disorders of Pregnancy in Shiraz, Southern Iran. Iranian
Cardiovascular Research Journal. ; vol 4: 169-172
Universitas Sumatera Utara